US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.5745
  • -0.0178-3.01%
Trading Dec 19 09:54 ET
2.92MMarket Cap-0.12P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
Aug 14, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Matinas BioPharma Earnings Reports

  • Matinas BioPharma | 10-Q: Q3 2024 Earnings Report

    Nov 13 17:23 ET

  • Matinas BioPharma | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

    Aug 14 16:53 ET

  • Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

    May 9 16:14 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Halozyme Therapeutics
    HALO
    +1.53%
    Hutchmed (China)
    HCM
    +1.10%
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +1.08%
    Teradata Corp
    TDC
    +1.04%
    Dorian LPG
    LPG
    +0.86%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data